RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Midatech Pharma Stock

Midatech Pharma Employees 2024

Midatech Pharma Employees

59

Ticker

MTPH.L

ISIN

GB00BKT14T00

In 2024, Midatech Pharma employed 59 people, a 0% change from the 0 number of employees in the previous year.

Midatech Pharma Aktienanalyse

What does Midatech Pharma do?

Midatech Pharma is an international biotechnology company specializing in the development and commercialization of innovative therapeutic products based on nanotechnology. The company was founded in 2000 and is headquartered in the UK. Its business model focuses on identifying disease areas with high medical needs and limited availability of effective therapies. By using nanoparticles, drugs are targeted to specific cells or tissue areas, increasing efficacy while minimizing side effects. Midatech Pharma has specialized in researching and developing products for rare diseases and cancer, with three business divisions: Midatech Pharma US, Midatech Pharma Europe, and Midatech Pharma Asia. Midatech Pharma US, located in Philadelphia, focuses on developing drugs for rare diseases, particularly for neurological disorders such as brain tumors and epilepsy. It has already received approvals for two novel drugs, including a spray for acute epilepsy seizures and a nasal spray formulation for treating carcinoid tumors. Midatech Pharma Europe, based in Bilbao, Spain, specializes in manufacturing and developing drugs for cancer, including innovative nanotechnology-based therapies for prostate cancer, pancreatic cancer, and hepatocellular carcinoma. The company has conducted several clinical studies in Europe and the US, including successful phase II trials for a drug treating pancreatic cancer. Midatech Pharma Asia, located in China, focuses on developing and marketing drugs for the Asian market, collaborating closely with local partners to establish a comprehensive distribution network. The company has already introduced several drugs for cancer and other diseases to the Asian market. Key products of Midatech Pharma include MTX110, an innovative drug for treating DIPG (diffuse intrinsic pontine glioma); MTX102, a nasal spray for treating benign carcinoid tumors; and MTX225, a novel drug formulation for treating prostate cancer. Overall, Midatech Pharma has established itself as a leading company in the field of nanotechnology-based drug development in recent years. With its focus on rare diseases and the synergy of innovation and market proximity, the company is well positioned for future success. Midatech Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Midatech Pharma's Employee Base

Midatech Pharma's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Midatech Pharma's operational capacity and future potential.

Year-to-Year Comparison

Assessing Midatech Pharma's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Midatech Pharma's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Midatech Pharma’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Midatech Pharma stock

How many employees does Midatech Pharma have this year?

Midatech Pharma has 59 undefined employees this year.

How many employees did Midatech Pharma have compared to the previous year?

Compared to the previous year, Midatech Pharma had 0% more employees.

What impact did the number of employees have on the company Midatech Pharma?

The number of employees has a direct impact on the efficiency and productivity of Midatech Pharma. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Midatech Pharma?

The number of employees can also have an impact on investors of Midatech Pharma, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Midatech Pharma affect the company?

An increase in equity of Midatech Pharma can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Midatech Pharma's equity affect the company?

A reduction in equity of Midatech Pharma can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Midatech Pharma?

Some factors that can influence the equity of Midatech Pharma include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Midatech Pharma so important for investors?

The equity of Midatech Pharma is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Midatech Pharma influence the company?

The number of employees at Midatech Pharma can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Midatech Pharma evolved in recent years?

In recent years, the number of employees at Midatech Pharma has changed by NaN.

How many employees does Midatech Pharma currently have?

Midatech Pharma currently has 59 undefined employees.

Why is the number of employees important for investors of Midatech Pharma?

The number of employees is important for investors of Midatech Pharma as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Midatech Pharma take to change the number of employees?

To change the number of employees, Midatech Pharma can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Midatech Pharma pay?

Over the past 12 months, Midatech Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Midatech Pharma is expected to pay a dividend of 0 GBP.

What is the dividend yield of Midatech Pharma?

The current dividend yield of Midatech Pharma is .

When does Midatech Pharma pay dividends?

Midatech Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Midatech Pharma?

Midatech Pharma paid dividends every year for the past 0 years.

What is the dividend of Midatech Pharma?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Midatech Pharma located?

Midatech Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Midatech Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Midatech Pharma from 11/4/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Midatech Pharma pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Midatech Pharma in the year 2023?

In the year 2023, Midatech Pharma distributed 0 GBP as dividends.

In which currency does Midatech Pharma pay out the dividend?

The dividends of Midatech Pharma are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Midatech Pharma

Our stock analysis for Midatech Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Midatech Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.